Teladoc Health, Inc. (LON:0LDR)
4.532
-0.058 (-1.27%)
Feb 12, 2026, 5:09 PM GMT
Teladoc Health Revenue
Teladoc Health had revenue of $626.44M USD in the quarter ending September 30, 2025, a decrease of -2.20%. This brings the company's revenue in the last twelve months to $2.53B, down -2.37% year-over-year. In the year 2024, Teladoc Health had annual revenue of $2.57B, down -1.26%.
Revenue (ttm)
$2.53B
Revenue Growth
-2.37%
P/S Ratio
0.32
Revenue / Employee
$459.67K
Employees
5,500
Market Cap
608.75M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.57B | -32.84M | -1.26% |
| Dec 31, 2023 | 2.60B | 195.58M | 8.13% |
| Dec 31, 2022 | 2.41B | 374.13M | 18.41% |
| Dec 31, 2021 | 2.03B | 938.75M | 85.81% |
| Dec 31, 2020 | 1.09B | 540.66M | 97.71% |
| Dec 31, 2019 | 553.31M | 135.40M | 32.40% |
| Dec 31, 2018 | 417.91M | 184.63M | 79.14% |
| Dec 31, 2017 | 233.28M | 110.12M | 89.42% |
| Dec 31, 2016 | 123.16M | 45.77M | 59.15% |
| Dec 31, 2015 | 77.38M | 33.86M | 77.78% |
| Dec 31, 2014 | 43.53M | 23.62M | 118.67% |
| Dec 31, 2013 | 19.91M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.67B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Spire Healthcare Group | 1.55B |
| CVS Group | 673.20M |
| Advanced Medical Solutions Group | 220.30M |
| Oxford Biomedica | 151.21M |
Teladoc Health News
- 3 days ago - Teladoc (TDOC) Sees Increased Bullish Activity in Options Market - GuruFocus
- 6 days ago - Teladoc (TDOC) Sees Surge in Bullish Option Activity - GuruFocus
- 6 days ago - Noteworthy Friday Option Activity: TDOC, CAH, STNG - Nasdaq
- 7 days ago - Teladoc Health to Announce Fourth Quarter 2025 Financial Results - GlobeNewsWire
- 10 days ago - Lightning Round: Just sell Teladoc, says Jim Cramer - CNBC
- 14 days ago - Teladoc hits all-time low as a risky pattern points to a deeper dive - Invezz
- 15 days ago - Once Medicare Stops Covering Telehealth Services, Will Teladoc Health Stock be in Trouble? - The Motley Fool
- 16 days ago - Are Telehealth Stocks Set to Tumble in 2026? - The Motley Fool